FDA Weighs Antidepressant Risks for Kids  BETHESDA, Md. (Reuters) - A U.S. advisory panel began  meeting Monday to debate whether certain antidepressants should  come with stronger warnings about the chances of suicidal  behavior in children and teens who take the drugs.